Article information
Full text is only aviable in PDF
Bibliografía
[1.]
Comité Científico del Estudio IBERPOC.
Proyecto IBERPOC: un estudio epidemiológico de la EPOC en España.
Arch Bronconeumol, 33 (1997), pp. 293-299
[2.]
N.G.M. Orie, H.J. Sluiter, K. De Vries.
The host factor in bronchitis.
En: Bronchitis, an international symposium, 27-29 April 1960, Universíty of Gróningen, (1961), pp. 43-49
[3.]
B. Burrows, J.W. Bloom, G. Traver, M.G. Cline.
The course and prognosis of different forms of chronic airways obstruction in a sample from the general population.
N Engl J Med, 317 (1987), pp. 1.309-1.314
[4.]
B. Burrows.
The course and prognosis of different types of chronic airflow limitation in a general population sample from Arizona: comparison with the Chicago “COPD” series.
Am Rev Respir Dis, 140 (1989), pp. 92-94
[5.]
D.S. Postma, J. Burema, F. Gimeno.
Prognosis in severe chronic obstructive pulmonary disease.
Am Rev Respir Dis, 119 (1979), pp. 357-367
[6.]
N.R. Anthonisen, J.E. Connett, J.P. Kiley, M.D. Altose, W.C. Bailey, S.A. Buist, et al.
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study.
JAMA, 272 (1994), pp. 1.497-1.505
[7.]
C. Silagy, M.D. Fowler, M. Lodge.
Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation.
Lancet, 343 (1994), pp. 139-142
[8.]
R.D. Hurt, D.P.L. Sachs, E.D. Glover, K.P. Offord, J.A. Johnston, P.D. Lowell, et al.
A comparison of sustained-release bupropion and placebo for smoking cessation.
N Engl J Med, 337 (1997), pp. 1.195-1.202
[9.]
V.M. Keatings, P.J. Barnes.
Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma and normal subjects.
Am J Respir Crit Care Med, 155 (1997), pp. 449-453
[10.]
M.C. Ronchi, C. Piragino, E. Rosi, M. Amendola, R. Duranti, G. Scano.
Role of sputum differential cell count int detecting airway inflammation in patients with chronic bronchial asthma or COPD.
Thorax, 51 (1996), pp. 1.000-1.004
[11.]
M. Linden, J. Bo, E. Piitulainen, A. Tunek, M. Larson, H. Tegner, et al.
Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis.
Am Rev Respir Dis, 148 (1993), pp. 1.226-1.232
[12.]
T. O'Shaugnessy, T.W. Ansari, C. Barnes, P. Jeffery.
Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1.
Am J Respir Crit Care Med, 155 (1997), pp. 852-857
[13.]
R. Finkelstein, R.S. Fraser, H. Ghezzo, M. Cosío.
Alveolar inflammation and its relation to emphysema in smokers.
Am J Respir Crit Care Med, 152 (1995), pp. 1.666-1.672
[14.]
A. Watson, T.K. Lim, H. Joyce, N. Pride.
Failure of inhaled corticosteroids to modify bronchoconstrictor or bronchodilator responsiveness in middle-aged smokers with mild airflow obstruction.
Chest, 101 (1992), pp. 350-355
[15.]
T. Engel, J.H. Heinig, O. Madsen, M. Hansen, E.R. Weeke.
A trial of inhaled budesonide on airway responsiveness in smokers with chronic bronchitis.
Eur Respir J, 2 (1989), pp. 935-939
[16.]
H.A.M. Kerstjens, P.L.P. Brand, M. Hughes, N.F. Robinson, D.S. Postma, H.J. Sluiter, et al.
A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease.
N Engl J Med, 327 (1992), pp. 1.413-1.419
[17.]
E. Dompeling, C.P. Van Schayck, P.M. Van Grunsven, C.L.A. Van Herwaarden, R. Akkermans, J. Molema, et al.
Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids.
Ann Intern Med, 118 (1993), pp. 770-778
[18.]
P. Chanez, A.M. Vignola, T. O'Shaugnessy, I. Enander, D. Li, P. Jeffery, et al.
Corticosteroid reversibility in COPD is related to features of asthma.
Am J Respir Crit Care Med, 155 (1997),
[19.]
F. Baranda, V. Sobradillo, N. Talayero, M. Pérez de las Casas, C. Badiola, E. Ciruelos, et al.
Estudio de la concordancia diagnóstica para las patologías asma y EPOC en pacientes ambulatorios.
Arch Bronconeumol, 34 (1998), pp. 9-13
[20.]
A.B. Thompson, M.B. Mueller, A.J. Heires, T.L. Bohling, et al.
Aerosolized beclomethasone in chronic bronchitis.
Am Rev Respir Dis, 146 (1992), pp. 389-397
[21.]
S.I. Rennard, D. Daughton, J. Fujita, M.B. Oerhlerking, A.B. Thompson.
Short-term smoking reduction is associated in measures of lower respiratory inflammation in heavy smokers.
Eur Respir J, 3 (1990), pp. 752-758
[22.]
C.M. Callaghan, R.S. Dittus, B.P. Katz.
Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease.
Ann Intern Med, 114 (1991), pp. 216-233
[23.]
P.L. Paggiaro, R. Dahle, I. Bakran, L. Frith, K. Hollingwort, J. Efthimiou.
Multicentre randomised placebo controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease.
Lancet, 351 (1998), pp. 773-780
[24.]
ATS Statement.
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 152 (1995), pp. 77-120
[25.]
ERS Consensus Statement.
Optimal assessment and management of chronic obstructive pulmonary disease (COPD).
Eur Respir J, 8 (1995), pp. 1.398-1.420
[26.]
BTS guidelines for the management of chronic obstructive pulmonary disease.
Thorax, 52 (1997), pp. 1-28
[27.]
P.J. Barnes.
New therapies for chronic obstructive pulmonary disease.
Thorax, 53 (1998), pp. 137-147
[28.]
N. Seersholm, M. Wencker, N. Banik, K. Viskum, A. Dirksen, A. Kok-Jensen.
Does alpha-l-antitrypsin augmentation therapy slow the anual decline in FEV1 in patients with severe hereditary alpha antitrypsin deficiency?.
Eur Respir J, 10 (1997), pp. 2.260-2.263
[29.]
F.P.V. Maesen, J.J. Smeets, M.A.L. Costongs, F.D.M. Wald, J.P.G. Cornelissen.
Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD).
Eur Respir J, 8 (1995), pp. 1.5061.513
[30.]
M. Cazzola, M.G. Matera, G. Santangelo, A. Vinciguerra, F. Rossi, G. D’Amato.
Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose response study.
Respir Med, 89 (1995), pp. 357-362
[31.]
Y. Lacasse, E. Wong, G.H. Guyatt.
Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease.
Lancet, 348 (1996), pp. 115-119
[32.]
P. De Lucas Ramos, J.M. Rodríguez González-Moro, J. García de Pedro, J.A. Dantacruz Siminiani, F. Tatay Martí, J.M. Cubillo Marcos.
Entrenamiento de los músculos inspiratorios en la enfermedad pulmonar obstructiva crónica. Su impacto sobre las alteraciones funcionales y sobre la tolerancia al ejercicio.
Arch Bronconeumol, 34 (1998), pp. 64-70
[33.]
P. Wijkstra, E.M. Ten Vergert, R. Van Altena.
Long-term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease.
Thorax, 50 (1995), pp. 824-828
[34.]
A. Órtqvist, J. Hedlung, L.A. Burman, E. Elbel, M. Hófer, M. Leinonen, et al.
Randomized trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people.
Lancet, 351 (1998), pp. 399-403
[35.]
J.P. Collet, S. Shapiro, P. Ernst, P. Renzi, T. Ducrute, A. Robinson.
Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 156 (1997), pp. 1.719-1.724
[36.]
J.A. Barbera, N. Roger, J. Roca, I. Rovira, T.W. Higenbottam, R. Rodríguez-Roisín.
Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease.
Lancet, 347 (1996), pp. 436-440
[37.]
L. Brochard, J. Mancebo, M. Wysocki.
Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease.
N Engl J Med, 333 (1995), pp. 817-822
[38.]
F. Barbé, B. Togores, M. Rubí, S. Pons, A. Maimó, A.G.N. Agustí.
Non-invasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease.
Eur Respir J, 9 (1996), pp. 1.240-1.245
[39.]
J.A. Wedzicha, D.J.M. Jones.
Domiciliary ventilation in chronic obstructive pulmonary disease: where and we?.
Thorax, 51 (1996), pp. 455-457
[40.]
P.A. Corris, T. Higenbottam, P. Goldstraw.
Surgical treatment for diffuse emphysema.
Eur Respir Monogr, 7 (1998), pp. 288-296
[41.]
J. Cooper, G. Patterson, R. Sundaresan, E.P. Trulock, R.D. Yusen, M.S. Pohl, et al.
Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema.
J Thorac Cardiovasc Surg, 112 (1996), pp. 1.319-1.330
[42.]
C. Roue, H. Mal, C. Sleiman.
Lung volume reduction in patients with severe diffuse emphysema.
Chest, 110 (1996), pp. 28-34
Copyright © 1999. Sociedad Española de Neumología y Cirugía Torácica
